EGFR and gastric cancer: In the MKN28 gastric cancer cell line, leptin treatment induced JAK2 and ERK1/2 activation through transactivation of the EGFR, which in turn seems to be dependent on the metalloproteinase-dependent release of EGFR ligands [165].